| Line Item | 2023-10-31 | Y/Y |
|---|---|---|
| Revenue | $2.64B | +13.1% |
| Cost of Revenue | $2.32B | +11.4% |
| Gross Profit | $316.1M | +27.7% |
| R&D Expense | $4.7M | +11.9% |
| SG&A Expense | $224.0M | +17.9% |
| Operating Income | $88.6M | +140.8% |
| Interest Expense | $28.6M | +69.2% |
| Pre-tax Income | $58.2M | +193.9% |
| Income Tax | $12.9M | +180.4% |
| Net Income | $45.3M | +198.0% |
| EPS (Basic) | $0.77 | +208.0% |
| EPS (Diluted) | $0.77 | +208.0% |
| Line Item | 2023-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.3M | +4.4% |
| Accounts Receivable | $226.5M | +5.3% |
| Inventory | $657.7M | +4.5% |
| Current Assets | $933.2M | +5.0% |
| Total Assets | $1.41B | +4.9% |
| Current Liabilities | $557.2M | +5.7% |
| Long-term Debt | $150.0M | -34.8% |
| Line Item | 2023-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $126.5M | +38.1% |
| Capital Expenditures | $32.8M | +32.3% |
| Investing Cash Flow | -$29.9M | -102.0% |
| Financing Cash Flow | -$95.7M | -37.3% |
| Free Cash Flow | $93.7M | +40.3% |
| Total Liabilities |
| $912.4M |
| +2.7% |
| Stockholders' Equity | $498.0M | +9.1% |